Ketamine treatment for obsessive-compulsive disorder symptoms
Treatments studied
Part of Mental health clinical trials.
This study tests whether ketamine can reduce obsessive-compulsive disorder (OCD) symptoms and how it affects stress and thinking. It also compares ketamine to usual care to see if benefits and side effects differ.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a primary diagnosis of obsessive-compulsive disorder (OCD)
- Your OCD symptom severity score is 16 or higher on the Yale-Brown OCD scale
- You can give informed consent in writing
- You have tried at least one other OCD treatment in the past
- You can follow all study rules and attend required visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a form of ketamine called RR-HNK as a possible new treatment for OCD. It is for people who have not gotten enough relief from standard treatments or chose not to take them.
This Phase 2 study tests how ketamine may work quickly in people with obsessive-compulsive disorder (OCD), especially after at least one standard treatment didn’t help. If you join, you’ll need to follow study procedures like fasting before the experimental visit and not enrolling in other medication trials during the study.
This trial looks at whether ketamine is safe and well-tolerated for certain mental health conditions when given in a hospital setting. It may help teams better understand side effects and comfort for people who may be offered ketamine.
This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.
This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.